ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07725
0,00%
Bitcoin
63.328,96
-0,88%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Prothena Corporation PLC (PRTA)

  7. Prothena Corporation PLC (PRTA) News

PRTA Prothena Corporation PLC

22,93
0,89 (4,04%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Prothena Corporation PLC PRTA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,89 4,04% 22,93 06:00:02
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
22,99 22,74 23,70 22,93 22,04
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202422:05BWProthena to Report First Quarter 2024 Financial Results on..
15.4.202422:05BWProthena Announces Review on Birtamimab Mechanism of Action..
06.3.202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202403:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.3.202422:05BWProthena to Participate in Upcoming Healthcare Conferences
04.3.202422:05BWProthena Appoints David Ford to Newly Created Chief People..
01.3.202403:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202403:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202403:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202403:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202423:29EDGAR2Form S-3ASR - Automatic shelf registration statement of..
22.2.202422:56EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21.2.202422:06EDGAR2Form 8-K - Current report
21.2.202422:05BWProthena Announces Appointment of Daniel G. Welch as..
15.2.202422:09EDGAR2Form 8-K - Current report
15.2.202422:05BWProthena Reports Fourth Quarter and Full Year 2023 Financial..
14.2.202418:16EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.2.202401:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.2.202422:05BWProthena to Report Fourth Quarter and Full Year 2023..
25.1.202401:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24.1.202422:06EDGAR2Form 144 - Report of proposed sale of securities
08.1.202414:35EDGAR2Form 8-K - Current report
08.1.202414:30BWProthena Provides Updates on PRX012, PRX123, Birtamimab and..
21.12.202301:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.12.202322:03EDGAR2Form 144 - Report of proposed sale of securities
01.12.202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.11.202322:05EDGAR2Form 144 - Report of proposed sale of securities
02.11.202321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02.11.202321:09EDGAR2Form 8-K - Current report
02.11.202321:05BWProthena Reports Third Quarter 2023 Financial Results and..
26.10.202322:05BWProthena to Report Third Quarter 2023 Financial Results on..
26.10.202302:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.10.202322:01EDGAR2Form 144 - Report of proposed sale of securities
12.10.202302:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.10.202322:02EDGAR2Form 144 - Report of proposed sale of securities
05.10.202301:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.10.202322:03EDGAR2Form 144 - Report of proposed sale of securities
28.9.202302:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.9.202322:01EDGAR2Form 144 - Report of proposed sale of securities
25.9.202322:56EDGAR2Form 144 - Report of proposed sale of securities
19.9.202323:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.9.202322:51EDGAR2Form 144 - Report of proposed sale of securities
14.9.202301:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.9.202301:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.9.202322:33EDGAR2Form 144 - Report of proposed sale of securities
13.9.202322:01EDGAR2Form 144 - Report of proposed sale of securities
07.9.202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
PRTA
Prothena
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten